SOP 207 Adverse Events: Identifying Recording and Reporting Adverse Events for Device Trials
The aim of this SOP is to describe the process for identifying recording and reporting of adverse events for device trials involving non-CE marked devices or CE marked devices that are being used outside their intended use s covered by the CE marking that require MHRA approval and are sponsored by the NNUH
Clinical GuidelinesThis guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.
The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.